News

Medscape3h
What Comes Next After Failure of Injectable HIV Medication?
After the virologic failure of cabotegravir/rilpivirine and despite dual-class resistance mutations, Canadian doctors have ...
WHO recommends Gilead's twice-yearly injection for HIV prevention
The World Health Organization on Monday recommended Gilead's lenacapavir, a twice-yearly injection, as a tool to prevent HIV ...
News-Medical.Net on MSN8h
Many HIV-exposed newborns miss preventive treatment after birth
Newborns exposed to HIV during pregnancy or birth should receive preventive antiretroviral medication immediately after ...
Minnesota recovers $256,000 in Medicaid dollars as part of fraud settlement with HIV drugmaker
State attorneys general and federal prosecutors alleged Gilead Sciences illegally bankrolled lavish events for prescribers.
ViiV expands licence to allow generic HIV treatment production for low-income countries
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
HIV prevention gets an AI upgrade
Artificial intelligence chatbots could help with the introduction of a twice-yearly shot that can help prevent HIV, experts ...
Lisa Jarvis: When an HIV scientific breakthrough isn’t enough
A landmark breakthrough in HIV prevention — a scientific feat decades in the making — received final approval from the Food ...
The Root on MSN14h
What The Hell! Scary Reasons For The Rise In HIV Amongst Black Women…Again
Black women make up just 13% of the U.S. female population, yet they account for over 50% of new HIV diagnoses among women, according to the Kaiser Family Foundation (KFF). That means more than half ...
Bhekisisa56m
SA gets R520-million to buy the twice-a-year anti-HIV jab — but there’s a snag
SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...